Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study

  1. Murray, M.
  2. Pulido, F.
  3. Mills, A.
  4. Ramgopal, M.
  5. LeBlanc, R.
  6. Jaeger, H.
  7. Canon, V.
  8. Dorey, D.
  9. Griffith, S.
  10. Mrus, J.
  11. Spreen, W.
  12. Margolis, D.
Aldizkaria:
HIV Research and Clinical Practice

ISSN: 2578-7470,  2578-7489

Argitalpen urtea: 2019

Alea: 20

Zenbakia: 4-5

Orrialdeak: 111-122

Mota: Artikulua

DOI: 10.1080/25787489.2019.1661696 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus